Viking Therapeutics, Inc. (NASDAQ:VKTX) Director Sells $715,850.00 in Stock

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) Director J Matthew Singleton sold 10,300 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $69.50, for a total value of $715,850.00. Following the completion of the transaction, the director now directly owns […]

Leave a Reply

Your email address will not be published.

Previous post Canaccord Genuity Group Trims Progyny (NASDAQ:PGNY) Target Price to $18.00
Next post Evergy (NYSE:EVRG) Now Covered by Analysts at Jefferies Financial Group